شیوع سندروم متابولیک و اجزای آن در بیماران مبتلا به استئو آرتریت

Background and Objective: Osteoarthritis (OA) is the most common bone-cartilage disease. It is well known that osteoarthritis is associated with obesity and various cardiovascular risk factors. Metabolic syndrome is a collection of cardiovascular risk factors. In this study, we assessed cardiovascular risk factors in patients with OA and their relationship with OA severity. Materials and Methods: This cross sectional study was conducted on 323 patients with OA in Zanjan, Iran, in 2010. Metabolic syndrome (Mets) was defined based on National Cholesterol Education Program (NCEP) and Adult Treatment Panel III (ATP III) criteria. Information on waist circumference, blood pressure, levels of blood sugar, triglyceride and HDL levels was collected and the severity of osteoarthritis was examined using WOMAC questionnaire. The level of insulin was measured for 234 of patients. Results: 93.2% of the patients were female and 6.8% were male. The mean age of the patients was 57.2 ± 9.4 year. The most prevalent site of osteoarthritis was knee (48.6%). According to the NCEP-ATP III criteria, the prevalence of Mets in these patients was 46.1%. The prevalence of Mets components was as follow: central obesity (53.3%), high triglyceride level (51.4%), hyperglycemia (33.4%), high blood pressure (61%), and low HDL level (43%). The mean score of the Iranian WOMAC questionnaire for the patients with Mets was higher (53.23) than that in the patients without Mets (41.65, P=0.003). The prevalence of Mets was also increased with increasing age. Insulin resistance was present for 35.7% of the patients. Conclusion: The prevalence of Mets was high in this population regardless of the OA type. In addition, Mets was more prevalent in patients with severe OA. This may indicate a relationship between the prevalence of Mets and the severity of OA. References 1- Rodrigues Pereira RM, De Carvalho JF. Bonfá E. Metabolic syndrome in rheumatological diseases. Autoimmunity Reviews. 2009 8: 415-41. 2- Kornaat PR, Sharma R, van der Geest RJ, et al. Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is oa also part of the metabolic syndrome? Skeletal Radiol. 2009: 38:1147-51. 3- Sowers MF, Hochberg M, Crabbe JP ,et al. Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. Am J Epidemiol. 1996 143: 38-48. 4- Felson DT. Osteoarthritis of the knee. Clinical practice. New Eng J Med. 2006 354: 841-48. 5- Davis MA, Neuhaus JM, Ettinger WH, Mueller WH. Body fat distribution and osteoarthritis. Am J Epidemiol. 1990 132: 701e7. 6- Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham Study. Ann Int Med. 1988 109: 18e24. 7- Felson DT, Zhang Y, Hannan MT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the framingham study. Arthritis Rheum. 1997 40: 728e33. 8- Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology. 1999 10: 161e6. 9- Moskowitz RW, Altman RD, Hochberg MC, Buckwalter VM. Risk factors in OA summarized in osteoarthritis, diagnosis and medical/surgical management. 4th ed. Philadelphia: Lippincott Williams & Wilkins 2007. 10- Davis MA. Epidemiology of osteoarthritis. Clin Geriatr Med. 1988 4: 241-55. 11- Van Saase JLCM, Vandenbroucke JP, Van Romunde LKJ, et al. Osteoarthritis and obesity in the general population: a relationship calling for explanation. J Rheumatol. 1988 15: 1152-8. 12- Moskowitz RW, Altman RD, Hochberg MC, Buckwalter VM. Risk factors in OA summarized in osteoarthritis, diagnosis and medical/surgical management. 4th ed. Philadelphia: Lippincott Williams & Wilkins 2007. 13- Kornaat PR, Bloem JL, Ceulemans RY, et al. Osteoarthritis of the knee: association between clinical features and MR imaging findings. Radiology. 2006 239: 811-7. 14- Maradee A, Davis M, Neuhaus, Walter H. Ettinger W, Mueller WH. Body fat distribution and osteoarthritis. Am J Epidemiol. 1990. 132: 701-7. 15- Rosner IA, Goldberg VM, Getzy L, et al. Effects of estrogen on cartilage and experimentally induced osteoarthritis. Arthritis Rheum. 1979 22: 52-8. 16- Bellino FL. Estrogen metabolism, not biosynthesis, in rabbit articular cartilage and isolated chondrocytes: a preliminary study. Steroids. 1992 57: 507-10. 17- Engstrom G, Gerhardsson de Verdier M, Rollof J, Nilsson M, Lohmander LS. C-reactive protein, metabolic syndrome and incidence of severe hip osteoarthritis. Osteoarthritis Cartilage. 2009 17: 168-73. 18- Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005 12: 295-300. 19- George A. Bellanger B, T Bellanger. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006 29: 109-17. 20- Janus ED, Laatikainen T, Dunbar JA, et al. Overweight, obesity and metabolic syndrome in rural southeastern Australia. Med J Aust. 2007 187: 147-52. 21- Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation. 2003 108: 1546-51. 22- Orellana C, Navarro N, Galisteo C, Gratacós J, Larrosa M. High prevalence of metabolic syndrome in patients with osteoarthritis. Osteoarthritis Cartilage. 2008 17: 110-15. 23- Velasquez MT, Katz JD. Osteoarthritis: another component of metabolic syndrome? Metab Syndr Relat Disord. 2010 4: 295-305. 24- Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997 389: 610-14. 25- Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1998 18: 1199-202. 26- Sellam J, Berenbaun F. Clinical features of osteoarthritis in: Firestein GF, Budd RC, Harris ED, et al. Kelleyś textbook of rheumatology.8th ed. Philadelphia: Elsevier. 2009 1547-61. 27- Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 285: 2486-97. 28- Gandhi R, Razak F, Davey JR, Mahomed NN. Asian ethnicity and the prevalence of metabolic syndrome in the osteoarthritic total knee arthroplasty population. J Arthroplasty. 2010 25: 416-19. 29- Korochina IE, Bagirova GG. Metabolic syndrome and a course of osteoarthritis. Ter Arkh. 2007 79: 13-20. 30- Nadrian H, Moghimi N, Nadrian E, et al. Validity and reliability of the persiom versions of WOMAC osteoarthritis index and lequesne algofunctional index. Clin Rheumatol. 2012 31: 1097-102.